HU182789B - Process for producing 3-beta-hydroxy-5-androsten-17-one - Google Patents
Process for producing 3-beta-hydroxy-5-androsten-17-one Download PDFInfo
- Publication number
- HU182789B HU182789B HU8018A HU1877A HU182789B HU 182789 B HU182789 B HU 182789B HU 8018 A HU8018 A HU 8018A HU 1877 A HU1877 A HU 1877A HU 182789 B HU182789 B HU 182789B
- Authority
- HU
- Hungary
- Prior art keywords
- androsten
- hydroxy
- cholestene
- prepared
- culture
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P33/00—Preparation of steroids
- C12P33/005—Degradation of the lateral chains at position 17
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
- C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
- C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
- C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0048—Alkynyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/863—Mycobacterium
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Steroid Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19762632677 DE2632677A1 (de) | 1976-07-16 | 1976-07-16 | Verfahren zur herstellung von androstan-17-on-derivaten und deren verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HU182789B true HU182789B (en) | 1984-03-28 |
Family
ID=5983514
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU8019A HU182790B (en) | 1976-07-16 | 1977-07-15 | Process for preparing 17beta-hydroxy-5-androstene derivatives |
| HU77SCHE614A HU179344B (en) | 1976-07-16 | 1977-07-15 | Process for producing andorstan-17-one derivatives |
| HU8020A HU182681B (en) | 1976-07-16 | 1977-07-15 | Process for preparing androstane derivatives |
| HU8018A HU182789B (en) | 1976-07-16 | 1977-07-15 | Process for producing 3-beta-hydroxy-5-androsten-17-one |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU8019A HU182790B (en) | 1976-07-16 | 1977-07-15 | Process for preparing 17beta-hydroxy-5-androstene derivatives |
| HU77SCHE614A HU179344B (en) | 1976-07-16 | 1977-07-15 | Process for producing andorstan-17-one derivatives |
| HU8020A HU182681B (en) | 1976-07-16 | 1977-07-15 | Process for preparing androstane derivatives |
Country Status (18)
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55148083A (en) * | 1979-05-04 | 1980-11-18 | Mitsubishi Chem Ind Ltd | Microorganism |
| JPS55150893A (en) * | 1979-05-11 | 1980-11-25 | Mitsubishi Chem Ind Ltd | Novel microorganism |
| JPS578794A (en) * | 1980-06-17 | 1982-01-18 | Mitsubishi Chem Ind Ltd | Preparation of androstane-type steroid |
| US4755463A (en) * | 1982-05-25 | 1988-07-05 | Wisconsin Alumni Research Foundation | Process for preparing steroids |
| US4444884A (en) * | 1982-05-25 | 1984-04-24 | Wisconsin Alumni Research Foundation | Process for preparing steroids |
| JPH0512528Y2 (US07816562-20101019-C00012.png) * | 1987-09-08 | 1993-03-31 | ||
| DE69621281T2 (de) * | 1995-02-28 | 2002-12-05 | Nippon Shokubai Co., Ltd. | Acryl-Säure-Derivate, Verfahren zur Herstellung von Acryl-Säure-Derivaten und Acryl-Säure-Polymere |
| PT2644206T (pt) * | 2003-05-23 | 2019-07-10 | Nektar Therapeutics | Derivados de peg contendo duas cadeias de peg |
| CN102656153B (zh) * | 2009-10-29 | 2015-02-18 | 延世大学校产学协力团 | 新型血管渗漏阻断剂 |
| US9388210B2 (en) | 2011-02-25 | 2016-07-12 | Washington University | Neuroactive 17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same |
| WO2013056181A1 (en) | 2011-10-14 | 2013-04-18 | Sage Therapeutics, Inc. | 3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof |
| SI2935307T1 (en) | 2012-12-18 | 2018-08-31 | Washington University | Non-reactive 19-alkoxy-17-substituted steroids useful in therapeutic procedures |
| US10202413B2 (en) | 2013-02-15 | 2019-02-12 | Washington University | Neuroactive enantiomeric 15-, 16- and 17-substituted steroids as modulators for GABA type-A receptors |
| US9512170B2 (en) | 2013-03-01 | 2016-12-06 | Washington University | Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors |
| US9365502B2 (en) | 2013-03-11 | 2016-06-14 | Washington University | Neuroactive substituted cyclopenta[b]phenanthrenes as modulators for GABA type-A receptors |
| US9562026B2 (en) | 2013-03-14 | 2017-02-07 | Washington University | Neuroactive substituted cyclopent[a]anthracenes as modulators for GABA type-A receptors |
| CA2909546C (en) | 2013-04-17 | 2019-01-22 | Sage Therapeutics, Inc. | 19-nor neuroactive steroids and methods of use thereof |
| KR102396328B1 (ko) | 2013-04-17 | 2022-05-10 | 세이지 테라퓨틱스, 인크. | 19-노르 c3,3-이치환된 c21-n-피라졸릴 스테로이드 및 그의 사용 방법 |
| US20160068563A1 (en) | 2013-04-17 | 2016-03-10 | Boyd L. Harrison | 19-nor neuroactive steroids and methods of use thereof |
| WO2014169831A1 (en) | 2013-04-17 | 2014-10-23 | Sage Therapeutics, Inc. | 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof |
| EP3868382A1 (en) | 2013-07-19 | 2021-08-25 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| DK3488852T3 (da) | 2013-08-23 | 2021-02-01 | Sage Therapeutics Inc | Neuroaktive steroider, sammensætninger og anvendelser deraf |
| WO2015195962A1 (en) | 2014-06-18 | 2015-12-23 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| EP3206494A4 (en) | 2014-10-16 | 2018-07-04 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| SI3206493T1 (sl) | 2014-10-16 | 2020-10-30 | Sage Therapeutics, Inc. | Sestavki in metode za zdravljenje CNS motenj |
| PL3224269T3 (pl) | 2014-11-27 | 2020-08-24 | Sage Therapeutics, Inc. | Kompozycje i sposoby leczenia zaburzeń OUN |
| SI3250210T1 (sl) | 2015-01-26 | 2021-07-30 | Sage Therapeutics, Inc. | Sestavki in metode za zdravljenje CNS motenj |
| WO2016134301A2 (en) | 2015-02-20 | 2016-08-25 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| MA45599A (fr) | 2016-07-11 | 2019-05-15 | Sage Therapeutics Inc | Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation |
| WO2018013615A1 (en) | 2016-07-11 | 2018-01-18 | Sage Therapeutics, Inc. | C7, c12, and c16 substituted neuroactive steroids and their methods of use |
| PE20230244A1 (es) | 2019-05-31 | 2023-02-07 | Sage Therapeutics Inc | Esteroides neuroactivos y composiciones de estos |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3451892A (en) * | 1965-10-19 | 1969-06-24 | Schering Corp | Process for the preparation of steroidal compounds |
| NL6705450A (US07816562-20101019-C00012.png) * | 1965-10-22 | 1968-10-21 | ||
| US3684657A (en) * | 1970-05-11 | 1972-08-15 | Searle & Co | Selective microbiological degradation of steroidal 17-alkyls |
| US3759791A (en) * | 1970-12-10 | 1973-09-18 | Searle & Co | Selective microbiological preparation of androst-4-ene-3,17-dione |
| US3738983A (en) * | 1971-08-06 | 1973-06-12 | Searle & Co | Process for the preparation of 3-(3beta,17beta-dihydroxyandrost-5-en-17alpha-yl) propionic acid gamma-lactone |
| DE2534911C2 (de) * | 1975-08-01 | 1985-04-18 | Schering AG, 1000 Berlin und 4709 Bergkamen | Verfahren zur Herstellung von 5-Androsten-17-on-Derivaten |
-
1976
- 1976-07-16 DE DE19762632677 patent/DE2632677A1/de active Granted
-
1977
- 1977-06-16 NL NL7706638A patent/NL7706638A/xx not_active Application Discontinuation
- 1977-07-01 YU YU01642/77A patent/YU164277A/xx unknown
- 1977-07-06 US US05/813,391 patent/US4179336A/en not_active Expired - Lifetime
- 1977-07-12 CH CH861377A patent/CH627190A5/de not_active IP Right Cessation
- 1977-07-13 AT AT0504677A patent/AT363196B/de not_active IP Right Cessation
- 1977-07-13 IE IE1456/77A patent/IE45304B1/en unknown
- 1977-07-13 CS CS774682A patent/CS200517B2/cs unknown
- 1977-07-14 DD DD7700200065A patent/DD132439A5/xx not_active IP Right Cessation
- 1977-07-14 DD DD77206205A patent/DD136141A5/xx unknown
- 1977-07-14 DD DD77206210A patent/DD137235A5/xx unknown
- 1977-07-14 SE SE7708192A patent/SE440779B/xx not_active IP Right Cessation
- 1977-07-14 DD DD77206207A patent/DD136142A5/xx unknown
- 1977-07-15 DK DK323677A patent/DK142372C/da not_active IP Right Cessation
- 1977-07-15 IT IT25807/77A patent/IT1077339B/it active
- 1977-07-15 BE BE179384A patent/BE856860A/xx not_active IP Right Cessation
- 1977-07-15 HU HU8019A patent/HU182790B/hu unknown
- 1977-07-15 HU HU77SCHE614A patent/HU179344B/hu not_active IP Right Cessation
- 1977-07-15 JP JP8493277A patent/JPS5315493A/ja active Granted
- 1977-07-15 GB GB29800/77A patent/GB1585786A/en not_active Expired
- 1977-07-15 HU HU8020A patent/HU182681B/hu unknown
- 1977-07-15 SU SU772502698A patent/SU980628A3/ru active
- 1977-07-15 HU HU8018A patent/HU182789B/hu unknown
- 1977-07-18 FR FR7721932A patent/FR2365588A1/fr active Granted
-
1978
- 1978-03-07 FR FR7806457A patent/FR2372176A1/fr active Pending
- 1978-03-07 FR FR7806455A patent/FR2372175A1/fr active Pending
- 1978-03-07 FR FR7806456A patent/FR2372174A1/fr active Pending
-
1981
- 1981-06-23 CH CH415281A patent/CH629222A5/de not_active IP Right Cessation
- 1981-06-23 CH CH415381A patent/CH629503A5/de not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU182789B (en) | Process for producing 3-beta-hydroxy-5-androsten-17-one | |
| US4230625A (en) | Process for chenodeoxycholic acid and intermediates therefore | |
| KR960013094B1 (ko) | 에이. 심플렉스(A. simplex)에 의한 스테로이드성 21-에스테르의 1,2-탈수소화 | |
| CS228517B2 (en) | Method for the production of macrolide | |
| US4301246A (en) | Process for chenodeoxycholic acid production | |
| US4255344A (en) | 9-α-Hydroxy steroids | |
| US7002028B2 (en) | 5-androsten-3β-ol steroid intermediates and processes for their preparation | |
| HU204574B (en) | Process for producing 4-androstene-3,17-dion and 1,4-androstadiene-3,17- - -dion with microbiological method | |
| HU189515B (en) | Process for preparing new 20-dihydro-20,23-dideoxy-tylonolide /tylactone/ and esters thereof | |
| HU183019B (en) | Process for preparing 5-androsten-17-one derivatives | |
| JPS6137280B2 (US07816562-20101019-C00012.png) | ||
| US4592868A (en) | 11-hydroxypregn-4-en-3-one-20-carbaldehyde and a method for its production | |
| US20070066579A1 (en) | 5-androsten-3beta-ol steroid intermediates and processs for their preparation | |
| CS200520B2 (cs) | Způsob výroby androstan-17-onových derivátů | |
| US3226305A (en) | Biological transformation of 1,3,10,11,12-pentahydroxynaphthacene - 2 - carboxamides to tetracycline antibiotics | |
| US20060100185A1 (en) | 5-Androsten-3beta-ol steroid intermediates and processes for their preparation | |
| SU1679977A3 (ru) | Способ получени 4-андростен-3,17-диона или 1,4-андростадиен-3,17-диона | |
| KR19990072026A (ko) | (11β,16β)-21-(아세틸옥시)-11-히드록시-2'-메틸-5'H-프레그나-1,4-디에노[17,16-D]옥사졸-3,20-디온의 제조 방법 | |
| JPS60105693A (ja) | 新規エストラン誘導体およびその製法 | |
| US4867913A (en) | 12α-substituted pregna-1,4-diene-3,20-diones | |
| US4432905A (en) | Simplified process for the degradation of steroid-C-22-carboxylic acids | |
| JPH0362718B2 (US07816562-20101019-C00012.png) | ||
| JPH05503218A (ja) | １７―オキソステロイドの製法 | |
| DE3248434A1 (de) | Verfahren zur herstellung von 3,11(alpha)-dihydroxy-1,3,5(10)-oestratrien-derivaten | |
| JPH0357919B2 (US07816562-20101019-C00012.png) |
